Xu, H.; Wang, X.; Zhu, F.; Guo, S.; Chao, Z.; Cao, C.; Lu, Z.; Zhu, H.; Wang, M.; Zhu, F.;
et al. Comprehensive Pan-Cancer Analysis of Connexin 43 as a Potential Biomarker and Therapeutic Target in Human Kidney Renal Clear Cell Carcinoma (KIRC). Medicina 2024, 60, 780.
https://doi.org/10.3390/medicina60050780
AMA Style
Xu H, Wang X, Zhu F, Guo S, Chao Z, Cao C, Lu Z, Zhu H, Wang M, Zhu F,
et al. Comprehensive Pan-Cancer Analysis of Connexin 43 as a Potential Biomarker and Therapeutic Target in Human Kidney Renal Clear Cell Carcinoma (KIRC). Medicina. 2024; 60(5):780.
https://doi.org/10.3390/medicina60050780
Chicago/Turabian Style
Xu, Huzi, Xiuru Wang, Fan Zhu, Shuiming Guo, Zheng Chao, Chujin Cao, Zhihui Lu, Han Zhu, Meng Wang, Fengming Zhu,
and et al. 2024. "Comprehensive Pan-Cancer Analysis of Connexin 43 as a Potential Biomarker and Therapeutic Target in Human Kidney Renal Clear Cell Carcinoma (KIRC)" Medicina 60, no. 5: 780.
https://doi.org/10.3390/medicina60050780
APA Style
Xu, H., Wang, X., Zhu, F., Guo, S., Chao, Z., Cao, C., Lu, Z., Zhu, H., Wang, M., Zhu, F., Yang, J., Zeng, R., & Yao, Y.
(2024). Comprehensive Pan-Cancer Analysis of Connexin 43 as a Potential Biomarker and Therapeutic Target in Human Kidney Renal Clear Cell Carcinoma (KIRC). Medicina, 60(5), 780.
https://doi.org/10.3390/medicina60050780
